Sign in
OMGA Stock Price, Chart, Stats & News
Omega Therapeutics, Inc.
Save
7.90M
Market cap
–
Current P/E
–
Forward P/E
OMGA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -2028.93% |
Operating margin | -3240.50% |
Pretax margin | -3148.93% |
Net margin | -3148.93% |
Effective tax rate | – |
ROA | -47.67% |
ROE | -118.82% |
D/E | 2.21x |
Interest coverage ratio | – |
OMGA valuation
P/E | – |
P/S | 2.55x |
P/B | 0.13x |
P/CF | -0.08x |
P/FCF | -0.08x |
P/OCF | -0.08x |
PEG | -0.01x |
EV multiple | 0.56x |
About
Omega Therapeutics, Inc. functions as a biopharmaceutical firm in its development phase. Its innovative OMEGA Epigenomic Programming platform leverages epigenetics—nature's fundamental system for gene regulation and cell differentiation—to engineer therapeutic solutions. The company is advancing various omega epigenomic controller (OEC) candidates to tackle a spectrum of diseases.
Similar securities
Based on sector and market capitalization
Report issue